Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer.
Tsai YY, Qu C, Bonner JD, Sanz-Pamplona R, Lindsey SS, Melas M, McDonnell KJ, Idos GE, Walker CP, Tsang KK, Da Silva DM, Moratalla-Navarro F, Maoz A, Rennert HS, Kast WM, Greenson JK, Moreno V, Rennert G, Gruber SB, Schmit SL. Tsai YY, et al. Among authors: gruber sb. Front Immunol. 2023 Oct 24;14:1268117. doi: 10.3389/fimmu.2023.1268117. eCollection 2023. Front Immunol. 2023. PMID: 37942321 Free PMC article.
Pathologic predictors of microsatellite instability in colorectal cancer.
Greenson JK, Huang SC, Herron C, Moreno V, Bonner JD, Tomsho LP, Ben-Izhak O, Cohen HI, Trougouboff P, Bejhar J, Sova Y, Pinchev M, Rennert G, Gruber SB. Greenson JK, et al. Among authors: gruber sb. Am J Surg Pathol. 2009 Jan;33(1):126-33. doi: 10.1097/PAS.0b013e31817ec2b1. Am J Surg Pathol. 2009. PMID: 18830122 Free PMC article.
PTPRJ haplotypes and colorectal cancer risk.
Toland AE, Rozek LS, Presswala S, Rennert G, Gruber SB. Toland AE, et al. Among authors: gruber sb. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2782-5. doi: 10.1158/1055-9965.EPI-08-0513. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18843023
Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway.
Vilar E, Mukherjee B, Kuick R, Raskin L, Misek DE, Taylor JM, Giordano TJ, Hanash SM, Fearon ER, Rennert G, Gruber SB. Vilar E, et al. Among authors: gruber sb. Clin Cancer Res. 2009 Apr 15;15(8):2829-39. doi: 10.1158/1078-0432.CCR-08-2432. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351759 Free PMC article.
337 results